A prospective examination of the effects of IL-1β, IL-6, and TNF-α on the development of Type 2 DM found that participants with detectable levels of IL-1β and elevated concentrations of IL-6 in plasma had a threefold increased risk of developing DM compared to the reference group [93]. The gene discussed is IL1B; the disease is diabetes mellitus.